Insider Transactions in Q2 2025 at Eye Point Pharmaceuticals, Inc. (EYPT)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 23
2025
|
Jay S. Duker President and CEO |
SELL
Other acquisition or disposition
|
Direct |
56,665
-98.29%
|
$453,320
$8.21 P/Share
|
|
May 25
2025
|
George Elston Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,202
-2.65%
|
$11,010
$5.68 P/Share
|
|
May 25
2025
|
George Elston Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+8.28%
|
-
|
|
May 19
2025
|
Karen L. Zaderej |
BUY
Open market or private purchase
|
Direct |
5,000
+12.05%
|
$25,000
$5.99 P/Share
|
|
May 16
2025
|
Karen L. Zaderej |
BUY
Open market or private purchase
|
Direct |
5,000
+13.7%
|
$25,000
$5.81 P/Share
|
|
May 15
2025
|
Karen L. Zaderej |
BUY
Open market or private purchase
|
Direct |
5,000
+15.87%
|
$25,000
$5.47 P/Share
|
|
May 14
2025
|
Karen L. Zaderej |
BUY
Open market or private purchase
|
Direct |
5,000
+18.87%
|
$25,000
$5.42 P/Share
|